Merrimack Pharmaceuticals, Inc.(MACK)

Sector:

Healthcare

Description:

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Merrimack Pharmaceuticals, Inc. website

Current Price

$12.62

RSI

56.01

Market Capitalization:

55.1M

Beta:

2.076

Volume:

56,339

Analyst Target Price:

$ 4

Economiic Fair Price:

Earnings DateNovember 02, 2022

Report DateNovember 03, 2022

QuarterQ3

Forward Dividend 57.70 %

Forward Dividend Rate N/A

Dividend 37.50 %

Dividend Rate $ 1.497

Payout Ratio N/A

Cash13.1M

Debt

EPS-0.23

Profit MarginN/A

Revenue Per Share TTM0

Return On Equity TTM-0.197

2016 Revenue

$ 144.3M

2021 Free Cash Flow

$ -218K

95.29 %

2020 Free Cash Flow

$ -4.6M

85.26 %

2019 Free Cash Flow

$ -31.4M

52.26 %

2018 Free Cash Flow

$ -65.7M

55.26 %

2017 Free Cash Flow

$ -146.9M

15.31 %

2016 Free Cash Flow

$ -173.4M

2016 Pre Tax Income

$ -153.5M